DJIA 17,106.70 29.83 0.17%
NASDAQ 4,570.64 13.29 0.29%
S&P 500 2,000.02 2.10 0.11%
market minute promo

Chimerix (NASDAQ: CMRX)

25.75 0.35 (1.38%)

Quote as of


company name or ticker

Recent Quotes

CMRX $25.75 1.38%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $25.50
Previous Close $25.40
Daily Range $25.35 - $25.87
52-Week Range $12.96 - $27.69
Market Cap $918.5M
P/E Ratio 362.86
Dividend (Yield) $0.00 (0.0%)
Volume 218,551
Average Daily Volume 209,296
Current FY EPS -$1.64

Sector

Industry

Chimerix (CMRX) Description

Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157. Website: http://www.chimerix.com/

News & Commentary Rss Feed

Why Chimerix, Inc. Shares Took Off

Chimerix shares rally following the close of its share offering. Find out what shareholders should have their eyes on instead.

Medtronic Unveils Viva CRT-P for Heart Failure Therapy in US - Analyst Blog

Chimerix's (CMRX) CEO Michelle Berrey on Q2 2014 Results - Earnings Call Transcript

Thursday 5/29 Insider Buying Report: GLAD, CMRX

Chimerix, Inc. (CMRX) Gains: Stock Up 13.9% - Tale of the Tape

Chimerix, Inc. (CMRX) Gains: Stock Up 13.9% - Tale of the Tape

Why Chimerix, Inc. Shares Flew Higher

Chimerix shares soar following a successful cash-raising effort. Find out what investors should really be watching with Chimerix going forward.

Weakness Seen in Chimerix (CMRX): Stock Tanks 15.5% - Tale of the Tape

Why Chimerix (CMRX) Stock Is Up Today

What Makes Chimerix (CMRX) a Strong Sell? - Tale of the Tape

Chimerix's (CMRX) CEO Michelle Berrey on Q1 2014 Results - Earnings Call Transcript

See More CMRX News...